The BCG availability status can be followed on the FDA website. The link below is directly to the expected January shortage notice. Suppliers are required to advise the FDA of expected supply problems in advance.
www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/Shortages/ucm351921.htm
From the link above,
"Because on increased global demand and as the only source of BCG Live (Intravesical) in the United States and many other countries, Merck anticipates supply constraints for TICE® BCG in 2019.
To minimize disruption to patient care and address the current imbalance between supply and increased global demand TICE® BCG will be under allocation when demand exceeds production plans and available inventory.
For questions, please call Merck customer service at:
1-800-NSC-MERCK
(1-800-672-6372)
Or visit
www.merck.com/product/
oncology/home.html
Click on link for the full story, or follow developments at the FDA site
Sweating over BCG once again,
Jack